UBA1 and chronic myelomonocytic leukemia: In the future, the order of UBA1 screening could be debated: integrated into the first-line genetic exploration of MDS as well as the MDS/SMP NGS panel or rather screened in the case of MDS/CMML with systemic features in particular USAID.